Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Net Cash Flow (2024 - 2025)

Hinge Health (HNGE) has disclosed Net Cash Flow for 2 consecutive years, with -$53.3 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 262.2% to -$53.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, down 94.18% year-over-year, with the annual reading at -$92.8 million for FY2025, 242.51% down from the prior year.
  • Net Cash Flow hit -$53.3 million in Q4 2025 for Hinge Health, down from $24.2 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $32.9 million in Q4 2024 to a low of -$53.3 million in Q4 2025.